P L Thompson

Summary

Affiliation: Western Australia
Country: Australia

Publications

  1. ncbi Under-ascertainment of Aboriginality in records of cardiovascular disease in hospital morbidity and mortality data in Western Australia: a record linkage study
    Tom G Briffa
    University of Western Australia, Crawley, Australia
    BMC Med Res Methodol 10:111. 2010
  2. ncbi Cardiovascular risk among urban Aboriginal people
    Peter L Thompson
    Western Australian Heart Research Institute, Sir Charles Gairdner Hospital, Nedlands, WA
    Med J Aust 179:143-6. 2003
  3. ncbi Effect of pravastatin compared with placebo initiated within 24 hours of onset of acute myocardial infarction or unstable angina: the Pravastatin in Acute Coronary Treatment (PACT) trial
    Peter L Thompson
    Department of Cardiovascular Medicine, Sir Charles Gairdner Hospital, Nedlands, Perth, WA, Australia
    Am Heart J 148:e2. 2004
  4. ncbi Clinical relevance of statins: instituting treatment early in acute coronary syndrome patients
    P L Thompson
    Departments of Medicine and Public Health, University of Western Australia, Department of Cardiovascular Medicine, Sir Charles Gairdner Hospital, 4th Floor, G Block, Nedlands, Perth, WA 6009, Australia
    Atheroscler Suppl 2:15-9. 2001
  5. ncbi Determinants of carotid intima-medial thickness in an urban Australian Aboriginal population
    Pamela J Bradshaw
    School of Population Health University of Western Australia, Nedlands, WA 6009, Australia
    Atherosclerosis 192:218-23. 2007
  6. ncbi Polymorphisms in the angiotensinogen gene are associated with carotid intimal-medial thickening in females from a community-based population
    C M Chapman
    Clinical Biochemistry, PathCentre, Locked Bag 2009, 6909, Nedlands, Australia
    Atherosclerosis 159:209-17. 2001
  7. ncbi Antioxidant vitamins and the risk of carotid atherosclerosis. The Perth Carotid Ultrasound Disease Assessment study (CUDAS)
    B M McQuillan
    Gairdner Campus of the Heart Research Institute of Western Australia, Western, Nedlands, Perth, Australia
    J Am Coll Cardiol 38:1788-94. 2001
  8. ncbi The C-480T hepatic lipase polymorphism is associated with HDL-C but not with risk of coronary heart disease
    P A McCaskie
    Laboratory for Genetic Epidemiology, Western Australian Institute for Medical Research, Centre for Medical Research, University of Western Australia, Nedlands, Perth, Western Australia
    Clin Genet 70:114-21. 2006
  9. ncbi Circulating adiponectin levels associate with inflammatory markers, insulin resistance and metabolic syndrome independent of obesity
    J Hung
    Sir Charles Gairdner Hospital Campus of the Heart Research Institute of Western Australia, Perth, Western Australia, Australia
    Int J Obes (Lond) 32:772-9. 2008
  10. ncbi The apolipoprotein AII rs5082 variant is associated with reduced risk of coronary artery disease in an Australian male population
    Jing Xiao
    Western Australian Institute for Medical Research, Centre for Medical Research, University of Western Australia, Australia
    Atherosclerosis 199:333-9. 2008

Detail Information

Publications40

  1. ncbi Under-ascertainment of Aboriginality in records of cardiovascular disease in hospital morbidity and mortality data in Western Australia: a record linkage study
    Tom G Briffa
    University of Western Australia, Crawley, Australia
    BMC Med Res Methodol 10:111. 2010
    ..We estimated the under-ascertainment of Aboriginal status in linked morbidity and mortality databases in patients hospitalised with cardiovascular disease...
  2. ncbi Cardiovascular risk among urban Aboriginal people
    Peter L Thompson
    Western Australian Heart Research Institute, Sir Charles Gairdner Hospital, Nedlands, WA
    Med J Aust 179:143-6. 2003
    ..To describe the results of a program for detecting high cardiovascular risk in an urban Aboriginal community...
  3. ncbi Effect of pravastatin compared with placebo initiated within 24 hours of onset of acute myocardial infarction or unstable angina: the Pravastatin in Acute Coronary Treatment (PACT) trial
    Peter L Thompson
    Department of Cardiovascular Medicine, Sir Charles Gairdner Hospital, Nedlands, Perth, WA, Australia
    Am Heart J 148:e2. 2004
    ..The efficacy of statin drugs after an acute coronary event is now well established, but the evidence for statin use in the early treatment of acute coronary events remains unclear...
  4. ncbi Clinical relevance of statins: instituting treatment early in acute coronary syndrome patients
    P L Thompson
    Departments of Medicine and Public Health, University of Western Australia, Department of Cardiovascular Medicine, Sir Charles Gairdner Hospital, 4th Floor, G Block, Nedlands, Perth, WA 6009, Australia
    Atheroscler Suppl 2:15-9. 2001
    ..The largest of these is the Australian Pravastatin Acute Coronary Treatment (PACT) study, which will compare early outcomes in patients treated with pravastatin versus placebo prescribed within the first 24 h of an acute coronary event...
  5. ncbi Determinants of carotid intima-medial thickness in an urban Australian Aboriginal population
    Pamela J Bradshaw
    School of Population Health University of Western Australia, Nedlands, WA 6009, Australia
    Atherosclerosis 192:218-23. 2007
    ..We studied the determinants of carotid atherosclerosis in urban-dwelling Australian Aboriginals at high risk of atherosclerotic mortality and morbidity...
  6. ncbi Polymorphisms in the angiotensinogen gene are associated with carotid intimal-medial thickening in females from a community-based population
    C M Chapman
    Clinical Biochemistry, PathCentre, Locked Bag 2009, 6909, Nedlands, Australia
    Atherosclerosis 159:209-17. 2001
    ..We investigated the association of polymorphisms in the angiotensinogen (AGT) and angiotensin II receptor type 1 (AGTR1) genes with increased intima-media thickness (IMT) and the presence of plaques in carotid arteries...
  7. ncbi Antioxidant vitamins and the risk of carotid atherosclerosis. The Perth Carotid Ultrasound Disease Assessment study (CUDAS)
    B M McQuillan
    Gairdner Campus of the Heart Research Institute of Western Australia, Western, Nedlands, Perth, Australia
    J Am Coll Cardiol 38:1788-94. 2001
    ..No benefit was demonstrated for supplemental antioxidant vitamin use...
  8. ncbi The C-480T hepatic lipase polymorphism is associated with HDL-C but not with risk of coronary heart disease
    P A McCaskie
    Laboratory for Genetic Epidemiology, Western Australian Institute for Medical Research, Centre for Medical Research, University of Western Australia, Nedlands, Perth, Western Australia
    Clin Genet 70:114-21. 2006
    ..19-0.78, p = 0.008). These findings replicate those of previous studies in three independent populations and suggest that the genetic determinants of CHD are complex and cannot be entirely explained through intermediate phenotypes...
  9. ncbi Circulating adiponectin levels associate with inflammatory markers, insulin resistance and metabolic syndrome independent of obesity
    J Hung
    Sir Charles Gairdner Hospital Campus of the Heart Research Institute of Western Australia, Perth, Western Australia, Australia
    Int J Obes (Lond) 32:772-9. 2008
    ..We examined whether the relationship between adiponectin and inflammatory markers, insulin resistance and MetS was independent of obesity...
  10. ncbi The apolipoprotein AII rs5082 variant is associated with reduced risk of coronary artery disease in an Australian male population
    Jing Xiao
    Western Australian Institute for Medical Research, Centre for Medical Research, University of Western Australia, Australia
    Atherosclerosis 199:333-9. 2008
    ..We conclude that the APOAII rs5082 polymorphism appears to be cardioprotective in this representative Caucasian Australian population...
  11. ncbi Interleukin-18 levels are not associated with subclinical carotid atherosclerosis in a community population. The Perth Carotid Ultrasound Disease Assessment Study (CUDAS)
    Caroline M L Chapman
    Clinical Biochemistry, PathWest, QEII Medical Centre, Perth, WA, Australia
    Atherosclerosis 189:414-9. 2006
    ..05). In a cross-sectional community population, IL-18 levels were related to traditional risk factors and inflammatory markers but were not independently associated with subclinical carotid atherosclerosis...
  12. ncbi Promoter polymorphism of the gene for CD14 receptor is not associated with sub-clinical carotid atherosclerosis in a community population
    Joseph Hung
    Sir Charles Gairdner Hospital Unit of the School of Medicine and Pharmacology, University of Western Australia, Perth, Western Australia
    Eur J Cardiovasc Prev Rehabil 11:344-9. 2004
    ..We examined if this polymorphism was associated with sub-clinical carotid atherosclerosis in a community population...
  13. ncbi Serum ferritin and C282Y mutation of the hemochromatosis gene as predictors of asymptomatic carotid atherosclerosis in a community population
    E Rossi
    Department of Clinical Biochemistry, PathCentre, Queen Elizabeth II Medical Centre, Nedlands, Western Australia
    Stroke 31:3015-20. 2000
    ..The purpose of the study was to test whether either is a risk predictor for asymptomatic carotid atherosclerosis...
  14. ncbi Preventing recurrent events long term after coronary artery bypass graft: suboptimal use of medications in a population study
    Pamela J Bradshaw
    School of Population Health, University of Western Australia, Perth, Australia
    Am Heart J 147:1047-53. 2004
    ..We assessed the prevalence and correlates of pharmacotherapy for prevention of new cardiac events in a large population-based series...
  15. ncbi Apolipoprotein E gene polymorphisms are associated with carotid plaque formation but not with intima-media wall thickening: results from the Perth Carotid Ultrasound Disease Assessment Study (CUDAS)
    John P Beilby
    PathCentre, Western Australian Centre for Pathology and Medical Research, Clinical Biochemistry, Nedlands, Western Australia, Australia
    Stroke 34:869-74. 2003
    ....
  16. ncbi Association of an allelic variant of interleukin-6 with subclinical carotid atherosclerosis in an Australian community population
    Caroline M L Chapman
    Clinical Biochemistry, Western Australian Centre for Pathology and Medical Research, Western Australia, Perth, Australia
    Eur Heart J 24:1494-9. 2003
    ..We examined the association of a common functional variant in the IL-6 gene with carotid intimal-medial wall thickness (IMT) and the presence of plaques in a randomly selected, cross-sectional Australian population...
  17. ncbi Early initiation of statin therapy after a coronary event
    Barry McKeown
    Department of Cardiovascular Medicine and Heart Research Institute, Sir Charles Gairdner Hospital, and West Australian Institute of Medical Research, Nedlands, Perth
    Curr Opin Lipidol 13:631-5. 2002
    ..Recent observational studies and randomized trials have addressed some of the questions regarding early initiation of statins in acute coronary syndromes...
  18. ncbi Stromelysin-1 (MMP-3) gene 5A/6A promoter polymorphism is associated with blood pressure in a community population
    John P Beilby
    Clinical Biochemistry, Western Australian Centre for Pathology and Medical Research PathCentre and School of Surgery and Pathology, University of Western Australia, Perth, Western Australia
    J Hypertens 23:537-42. 2005
    ..Stromelysin-1 gene expression is partly regulated by a common polymorphism in the promoter region of either five or six consecutive adenosine bases (5A/6A)...
  19. ncbi Role of coronary interventional procedures in improved postinfarction survival in the 1990s
    C Blanton
    Department of Medicine, University of Western Australia, Western Perth, Australia
    Am J Cardiol 87:832-7. 2001
    ....
  20. ncbi Investigating the association between K198N coding polymorphism in EDN1 and hypertension, lipoprotein levels, the metabolic syndrome and cardiovascular disease
    Steven Wiltshire
    Western Australian Institute for Medical Research and UWA Centre for Medical Research, University of Western Australia, Perth, Australia
    Hum Genet 123:307-13. 2008
    ..In conclusion, we found no robust evidence for the associations between K198N and hypertension, systolic blood pressure or HDL levels seen in previous studies...
  21. ncbi 15-Lipoxygenase gene variants are associated with carotid plaque but not carotid intima-media thickness
    Pamela A McCaskie
    Laboratory for Genetic Epidemiology, Western Australian Institute for Medical Research, UWA Centre for Medical Research, University of Western Australia, Perth, WA, Australia
    Hum Genet 123:445-53. 2008
    ..This study is novel as it is the first to examine the association between 15-lipoxygenase polymorphisms and atherosclerotic indicators. These findings suggest a possible role of ALOX15 polymorphisms in focal plaque formation...
  22. ncbi Cholesteryl ester transfer protein gene haplotypes, plasma high-density lipoprotein levels and the risk of coronary heart disease
    Pamela A McCaskie
    Laboratory for Genetic Epidemiology, Western Australian Institute for Medical Research, UWA Centre for Medical Research, University of Western Australia, Nedlands, WA, 6009, Australia
    Hum Genet 121:401-11. 2007
    ..These results suggest that raising HDL-C via CETP inhibition may not alter risk of CHD. Randomized control trials are needed to determine whether CETP inhibition will in reality reduce risk of CHD by raising HDL-C...
  23. ncbi Effect of colchicine (0.5 mg twice daily) on high-sensitivity C-reactive protein independent of aspirin and atorvastatin in patients with stable coronary artery disease
    Mark Nidorf
    West Australian Heart Research Institute, Sir Charles Gairdner Hospital, Perth, Western Australia, Australia
    Am J Cardiol 99:805-7. 2007
    ..Additional controlled studies are warranted to confirm this observation and determine whether long-term use of low-dose colchicine can improve clinical outcomes in patients with advanced vascular disease...
  24. ncbi Mortality and recurrent cardiac events after coronary artery bypass graft: long term outcomes in a population study
    P J Bradshaw
    School of Population Health, University of Western Australia, Western Australia, Australia
    Heart 88:488-94. 2002
    ..To determine 30 day mortality, long term survival, and recurrent cardiac events after coronary artery bypass graft (CABG) in a population...
  25. ncbi A Pro12Ala polymorphism in the human peroxisome proliferator-activated receptor-gamma 2 is associated with combined hyperlipidaemia in obesity
    M M Swarbrick
    Department of Clinical Biochemistry, PathCentre, Nedlands, Western Australia 6009, Australia
    Eur J Endocrinol 144:277-82. 2001
    ..The aim of this investigation was to determine whether a PPAR gamma 2 Pro12Ala polymorphism was associated with cardiovascular risk factors (obesity, blood pressure, diabetes and blood lipids) in Western Australian Caucasians (n=663)...
  26. ncbi Elevated interleukin-18 levels are associated with the metabolic syndrome independent of obesity and insulin resistance
    Joseph Hung
    Sir Charles Gairdner Hospital Campus of the Heart Research Institute of Western Australia, and School of Medicine and Pharmacology, University of Western Australia, Nedlands, Perth
    Arterioscler Thromb Vasc Biol 25:1268-73. 2005
    ..We sought to determine whether an elevated IL-18 concentration was a risk predictor for metabolic syndrome in a community population independent of obesity and hyperinsulinemia...
  27. ncbi Erectile dysfunction predicts generalised cardiovascular disease: evidence from a case-control study
    Bronwyn G A Stuckey
    Keogh Institute for Medical Research, Nedlands, WA, Australia
    Atherosclerosis 194:458-64. 2007
    ..To determine whether idiopathic erectile dysfunction, in the absence of overt cardiovascular disease or cardiovascular risk factors, is associated with vascular or autonomic dysfunction...
  28. ncbi Association of Interleukin-1 gene polymorphisms with central obesity and metabolic syndrome in a coronary heart disease population
    Kim W Carter
    Western Australian Institute for Medical Research and UWA Centre for Medical Research, University of Western Australia, Perth, WA, Australia
    Hum Genet 124:199-206. 2008
    ....
  29. ncbi Hemodynamic effects of fenofibrate and coenzyme Q10 in type 2 diabetic subjects with left ventricular diastolic dysfunction
    Gerard T Chew
    School of Medicine and Pharmacology, University of Western Australia, Perth, Western Australia, Australia
    Diabetes Care 31:1502-9. 2008
    ..To investigate the effects of fenofibrate and coenzyme Q(10) (CoQ) on diastolic function, ambulatory blood pressure (ABP), and heart rate (HR) in type 2 diabetic subjects with left ventricular diastolic dysfunction (LVDD)...
  30. ncbi Coronary heart disease events in Aboriginal Australians: incidence in an urban population
    Pamela J Bradshaw
    School of Population Health, University of Western Australia, Perth, WA, Australia
    Med J Aust 190:583-6. 2009
    ..To determine the incidence of coronary heart disease (CHD) events in an urban Aboriginal population...
  31. ncbi Patient delay in responding to symptoms of possible heart attack: can we reduce time to care?
    Judith C Finn
    Centre for Nursing Research, Sir Charles Gairdner Hospital, and School of Population Health, University of Western Australia, Perth, WA, Australia
    Med J Aust 187:293-8. 2007
    ..The National Heart Foundation of Australia proposes a comprehensive strategy to incorporate this approach into its future campaigns to reduce patient delay for suspected heart attack...
  32. ncbi Measuring the gap: accuracy of the Western Australian hospital morbidity data in the identification of adult urban Aboriginal and Torres Strait Islander people
    Pamela J Bradshaw
    School of Population Health, University of Western Australia, Australia
    Aust N Z J Public Health 33:276-9. 2009
    ..To assess the sensitivity of the recording of Aboriginality in the Western Australia Linked Data...
  33. ncbi Return to work after coronary artery bypass surgery in a population of long-term survivors
    Pamela J Bradshaw
    School of Population Health, The University of Western Australia, M431, 35 Stirling Highway, Crawley, WA 6009, Australia
    Heart Lung Circ 14:191-6. 2005
    ..Return to paid employment may be facilitated by coronary artery bypass graft (CABG) surgery. We assessed work status in a population-based study of long-term outcomes of CABG...
  34. ncbi Association of PARL rs3732581 genetic variant with insulin levels, metabolic syndrome and coronary artery disease
    Brenda L Powell
    Western Australian Institute for Medical Research, UWA Centre for Medical Research, University of Western Australia, Perth, Australia
    Hum Genet 124:263-70. 2008
    ..There were significant effects of the variant on mean IMT and risk of CAD. A role for PARL in metabolic conditions cannot be excluded and more comprehensive genetic studies are warranted...
  35. ncbi Folic acid does not improve endothelial function in healthy hyperhomocysteinaemic subjects
    Richard J Woodman
    School of Medicine and Pharmacology, University of Western Australia, West Australian Institute of Medical Research, GPO Box X2213, Perth, WA 6847, Australia
    Clin Sci (Lond) 106:353-8. 2004
    ..7 +/- 0.5%; P = 0.17 compared with placebo). In healthy subjects with hyperhomocysteinaemia, but without additional cardiovascular risk, endothelial function is unimpaired and folic acid supplementation has no additional effect...
  36. ncbi Monocyte count, but not C-reactive protein or interleukin-6, is an independent risk marker for subclinical carotid atherosclerosis
    Caroline M L Chapman
    Clinical Biochemistry, Western Australian Centre for Pathology and Medical Research, Perth, Western Australia
    Stroke 35:1619-24. 2004
    ..Monocyte count may represent an inexpensive, easy-to-measure risk marker for subclinical carotid atherosclerosis...
  37. ncbi Effects of intensive versus moderate lipid-lowering therapy on myocardial ischemia in older patients with coronary heart disease: results of the Study Assessing Goals in the Elderly (SAGE)
    Prakash Deedwania
    UCSF School of Medicine, San Francisco, Calif, USA
    Circulation 115:700-7. 2007
    ..However, no studies to date have assessed intensive versus moderate statin therapy in older patients with stable coronary syndromes...
  38. ncbi Effects of early treatment with statins on short-term clinical outcomes in acute coronary syndromes: a meta-analysis of randomized controlled trials
    Matthias Briel
    Basel Institute for Clinical Epidemiology, University Hospital Basel, Basel, Switzerland
    JAMA 295:2046-56. 2006
    ..CONCLUSION: Based on available evidence, initiation of statin therapy within 14 days following onset of ACS does not reduce death, MI, or stroke up to 4 months...
  39. ncbi Sex in the CCU: women with non-ST-segment elevation acute coronary syndrome may do no worse despite less intervention
    Pamela J Bradshaw
    Heart 93:1327-8. 2007
  40. ncbi Asymptomatic long-term survivors of coronary artery bypass surgery enjoy a quality of life equal to the general population
    Pamela J Bradshaw
    Institute for Clinical Evaluative Sciences, Toronto, Ontario, Canada
    Am Heart J 151:537-44. 2006
    ..Health-related quality of life (HRQOL) among long-term survivors of coronary artery bypass surgery is an important outcome that has been little studied at the population level...